First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension

Tang W, Wong GWK, Perez MI, Wright JM

Published Online:

October 7, 2009

This is the protocol for a review and there is no abstract. The objectives are as follows:

To evaluate the benefits and harms of drugs inhibiting the RAS in patients with elevated blood pressure (>130/85mmHg).

Abstract (click to read)

This record should be cited as:

Tang W, Wong GWK, Perez MI, Wright JM. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension. Cochrane Database of Systematic Reviews 2009, Issue 4. Art. No.: CD008170. DOI: 10.1002/14651858.CD008170

Assessed as up to date:

July 27, 2009

Find the research

Get full text at The Cochrane Library

Primary Review Group:

Hypertension Group

Cochrane Summaries^beta

Independent high-quality evidence for health care decision making

First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension

More like this

Copyright © 2012 - The Cochrane Collaboration